We help researchers in unmet medical need analysis of diseases which helps them in disease prioritization for any new drug/device/target/MOA development. We do unmet medical need analysis of any disease based on various parameters which is not limited to quality of available therapy, patient perspective, payer & providers perspective.
We also map pipeline drugs clinical data to current unmet need & evaluate residual unmet medical need. It helps researchers to identify target areas for new drug development.
